New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School at Houston 77030, USA.
D000818:Animals; D000963:Antimetabolites; D001379:Azathioprine; D001713:Biphenyl Compounds; D002454:Cell Differentiation / Q000187:drug effects; D016572:Cyclosporine; D006146:Guanidines; D006801:Humans; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D008214:Lymphocytes / Q000166:cytology; D008222:Lymphokines / Q000096:biosynthesis; D016376:Oligonucleotides, Antisense; D011090:Polyenes; D018121:Receptors, Cytokine / Q000037:antagonists & inhibitors; D012263:Ribonucleosides; D015398:Signal Transduction; D020123:Sirolimus; D016559:Tacrolimus; D011798:Quinaldines
D000963:Antimetabolites; D001379:Azathioprine; D001713:Biphenyl Compounds; D016572:Cyclosporine; D006146:Guanidines; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D008222:Lymphokines; D016376:Oligonucleotides, Antisense; D011090:Polyenes; D018121:Receptors, Cytokine; D012263:Ribonucleosides; D020123:Sirolimus; D016559:Tacrolimus; C010052:mizoribine; C046943:brequinar; D011798:Quinaldines; C037258:gusperimus